Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Da Kine's Profile
Displaying 1-43 of 43 result(s).
CYDY CytoDyn Inc
05/22/2025 8:19:15 PM
Reading some of these posts reminds (4)
CYDY CytoDyn Inc
02/12/2025 7:59:00 PM
Cutting NIH funding at OHSU and els (7)
CYDY CytoDyn Inc
12/01/2024 8:31:12 PM
Fascinating interview with a scienc (8)
CYDY CytoDyn Inc
07/27/2024 3:44:54 AM
We are not one of the 23 companies (8)
CYDY CytoDyn Inc
02/10/2024 12:46:49 PM
With the settlement looming and the (2)
CYDY CytoDyn Inc
12/14/2023 3:40:57 PM
Link for today's conference call (1)
CYDY CytoDyn Inc
11/03/2023 5:28:19 PM
Shareholder letter and FAQ's are gr (9)
CYDY CytoDyn Inc
08/13/2023 2:52:51 PM
The high and low estimates also sta (3)
CYDY CytoDyn Inc
10/12/2022 2:55:52 PM
According to 10Q, 3 new SAB members (7)
CYDY CytoDyn Inc
09/07/2022 1:37:04 PM
No. Same as they were last week and
CYDY CytoDyn Inc
07/08/2022 7:03:46 PM
Strange, looks like someone took th (1)
CYDY CytoDyn Inc
06/21/2022 2:41:18 AM
Great read from the patent applicat (15)
CYDY CytoDyn Inc
03/04/2022 4:20:33 PM
Leronlimab is an investigational dr (3)
CYDY CytoDyn Inc
02/08/2022 9:02:29 PM
The need be. You can't "fire" the r (7)
CYDY CytoDyn Inc
01/06/2022 7:51:50 PM
Heads up; the information was conta (7)
CYDY CytoDyn Inc
12/15/2021 8:27:46 PM
Amarex has helped obtain the follow (11)
CYDY CytoDyn Inc
12/14/2021 12:31:21 PM
Tanya D Urbach is not a dermatologi (7)
CYDY CytoDyn Inc
12/10/2021 1:09:02 PM
New CRO for CytoDyn, at least for t (8)
CYDY CytoDyn Inc
11/25/2021 8:25:53 PM
What's the issue with Jordan Nayden (1)
CYDY CytoDyn Inc
10/23/2021 3:57:24 PM
$820 per patient, 50 patients =$41, (2)
CYDY CytoDyn Inc
10/13/2021 2:21:44 PM
Wrong again. Severe started Septemb (2)
CYDY CytoDyn Inc
09/30/2021 8:52:31 PM
CD17 Severe will have 35 sites. Fir (9)
CYDY CytoDyn Inc
09/27/2021 9:11:48 PM
Where is IncellDx in five years? We (3)
CYDY CytoDyn Inc
04/17/2021 5:12:23 PM
Looks to me like we are selling ler (12)
CYDY CytoDyn Inc
04/12/2021 8:22:22 PM
Gilead Sciences said on Monday it h (2)
CYDY CytoDyn Inc
03/07/2021 5:09:30 PM
A year ago they said they'd file in
CYDY CytoDyn Inc
03/07/2021 4:39:17 PM
Timeline for HIV BLA from Feb 22 PR (1)
CYDY CytoDyn Inc
01/30/2021 12:41:53 PM
Does yesterdays 8k filing help to o
CYDY CytoDyn Inc
01/29/2021 3:24:04 PM
You'll find it at 44:45 mark https: (1)
CYDY CytoDyn Inc
01/06/2021 5:14:40 PM
Just the opposite. Improved SOC did (7)
CYDY CytoDyn Inc
12/21/2020 2:42:51 AM
I think that job posting was create
CYDY CytoDyn Inc
11/05/2020 5:18:07 PM
Unknown billionaire ready to step i (1)
CYDY CytoDyn Inc
11/05/2020 4:48:51 PM
Operation Warp Speed! Confirmed com (3)
CYDY CytoDyn Inc
10/07/2020 5:51:26 PM
SEC and Financial Reporting Manager (3)
CYDY CytoDyn Inc
09/02/2020 10:22:56 PM
Do I have this right? Cytodyn's 201 (9)
CYDY CytoDyn Inc
08/27/2020 1:48:29 PM
"While it generally takes four to s
CYDY CytoDyn Inc
08/23/2020 5:57:06 PM
I feel like the bar for EUA has bee (1)
CYDY CytoDyn Inc
08/19/2020 6:05:53 PM
justdafacts, venture cap, 3x charm (3)
CYDY CytoDyn Inc
08/17/2020 4:15:59 PM
Just me or has the Proactive Video
CYDY CytoDyn Inc
08/14/2020 12:56:05 AM
Thanks for being such prolific post (1)
CYDY CytoDyn Inc
08/12/2020 4:53:02 PM
Bruce Patterson and CytoDyn are joi (2)
CYDY CytoDyn Inc
08/07/2020 8:37:18 PM
What happens if leronlimab fails to
CYDY CytoDyn Inc
06/26/2020 9:22:25 PM
Aloha, If FDA asks for a phase 3 fo

Recent Articles

  • Investors Unite to Challenge Snap Inc. Securities Fraud Allegations
  • Hyland Launches AI Innovations for Enhanced Enterprise Automation
  • Exploring Migration: The 2025 Earl Lecture Series at PSR
  • Celebrating Icelandic Culture: Taste of Iceland Festival in Boston
  • Transforming Healthcare Supply Chains with Eric O'Daffer at LogicSource
  • Cox Farms Hits Milestone with 2 Million Pounds Donated
  • Investors Urged to Lead Class Action Against Western Asset
  • Investors Urged to Act: iRobot Class Action Deadline Approaches
  • BJ's Restaurants, Inc. Engages at the Growth Frontiers Conference
  • Allsup Unveils New Conditions for Faster Disability Benefits
  • Significant Additions to Compassionate Allowances for SSDI
  • Exploring Dorian LPG Inc's Current Financial Position and Metrics
  • Stellantis Makes Bold Move with $41 Million Investment for Efficiency
  • Quantum Innovation: AMD and IBM Join Forces, While Nvidia Soars
  • Biohaven Investors: Join the Class Action for Justice Today
  • Understanding Current Trends in CrowdStrike Holdings' Options Market
  • Analyzing the Recent Options Activity of Kinross Gold Corp
  • Carlos Hank González Honored for Leadership at Banorte
  • Analyzing Intricacies of Seagate Technology's Options Trading
  • Investors Seek Justice in iRobot Corporation Securities Case
  • Upcoming Housing Initiative Announcement in Granby: Key Details
  • CIMG Inc. Secures $55 Million via Bitcoin Stock Exchange
  • Meta's $50 Billion Data Center Surge: What Investors Should Know
  • Investors Urged to Act in Ongoing Petco Fraud Litigation
  • New Opportunities and Collaborations in Behavioral Health
  • TAKE Token Experiences Impressive Growth Post-Listing
  • Electric Vehicle Sales Drive Growth in New Vehicle Market
  • Adams County Electric Upgrade Enhances Community Reliability
  • Stacey Posey Appointed COO of American Track for Growth
  • CATL Launches Innovative TENER Stack at Energy Expo 2025
  • Navigating Retirement Across Borders: Your Essential Guide
  • XPPen Enhances Creativity with PUBG MOBILE Design Contest
  • Examining the Latest Trends in Ad Fraud Across EMEA
  • Mobile Clinics Market Growth: Meeting Healthcare Needs Efficiently
  • Exploring the Growth Potential of the Global Pharmaceuticals Market
  • Decline in Canadian Small Business Confidence Amid Rising Costs
  • Archer Aviation Faces Criticism from Short Sellers Amid Competition
  • Serve Robotics Experiences Impressive Stock Growth Today
  • Transforming Agriculture: HECTR's Innovative Blockchain IEO
  • Understanding Your Rights as a KBR Investor Amidst Recent Events
  • BJ's Restaurants Showcases Leadership at Upcoming Conference
  • Understanding Tesla's Stock Performance Amid Challenges
  • Raymond James Strengthens Team with Experienced Advisors
  • Snowflake Inc: Anticipation Grows for Q2 Earnings Results
  • Pfizer and BioNTech Launch New COVID-19 Vaccine for At-Risk Groups
  • Amylyx Pharmaceuticals Ends AMX0035 Program Following Trial Setbacks
  • Bitcoin's $117,570 Challenge: Implications for the Market
  • MAISON PERRIER Introduces Charles Mackenzie and Josh Koby
  • Major Benefits Transformation for Whole Foods Employees
  • Ten-Year Investment Journey: Discover Your Potential Gains
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site